Paltimatrectinib
Paltimatrectinib (PBI-200) is a potent and selective TrkA tyrosine kinase inhibitor used in cancer research. It has demonstrated activity in preclinical studies of bladder, breast, and colorectal cancers, showing potential in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
2353522-15-1
Product Name Alternative
PBI-200, PPI-5278, Trk receptor, TrkA, Trkreceptor, Tyrosine Kinases, TyrosineKinases
Field of Research
Protein Biochemistry, Signal Transduction
Purity
99.96% (May vary between batches)
Solubility
DMSO:10 mg/mL (23.02 mM)
Smiles
[H][C@@]1 (CCCN1c1ccn2ncc (-n3cc (cn3) C (F) (F) F) c2n1) c1cc (F) ccc1F
Molecular Formula
C20H15F5N6
Molecular Weight
434.37
Storage Conditions
-20°C
Notes
For research use only.
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1326704 1.0 µg DNA
MRPL9 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details